Information Provided By: 
Fly News Breaks for January 6, 2020
NVS, SNY
Jan 6, 2020 | 08:57 EDT
JPMorgan analyst Richard Vosser upgraded Sanofi (SNY) to Overweight from Neutral with a price target of EUR 103, up from EUR 81. Sanofi should start to close the valuation gap relative to peers in 2020, Vosser tells investors in a research note. The analyst believes the stock's current multiple of 12.6 times is "unjustified," especially when Novartis (NVS) trades on 14.3 times for a similar growth profile of 2.7%. He also also sees the potential for earnings upgrades driven by Dupixent.
News For SNY;NVS From the Last 2 Days
NVS
Apr 23, 2024 | 06:36 EDT
NVS
Apr 23, 2024 | 06:35 EDT
SNY
Apr 22, 2024 | 12:15 EDT
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
SNY
Apr 22, 2024 | 11:36 EDT
